Pt-Rep Urinary & Bowel QoL Following EBRT +/- HDR Brachy Boost: Post-Hoc Analyses of TROG 03.04 (RADAR) #ASTRO23 UroToday.com Wee Loon Ong 🔹n=260 EBRT, n=237 EBRT + HDR brachy Boost 🔹At 12, 18, 24, & 36 mos, EBRT + brachy boost was 2.4x, 3.1x (p < 0.001), 2.8x (p < 0.001), & 2.5x

In patients with high-risk biochemically recurrent prostate cancer, treatment with enzalutamide and leuprolide improved metastasis-free survival as compared with leuprolide alone. Read the full results of the EMBARK phase 3 trial): nej.md/402Jenp

Click below for a comprehensive historical review by Wee Loon Ong on "The March Toward Single‑Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer—Quo Vadimus?" tinyurl.com/2zkbfspz

Registration is now open for the RANZCR Statistical Methods, Evidence Appraisal and Research for Trainees (SMART) Workshop, taking place on Tues 12 March 2024 in Newcastle NSW. Learn more and register here >> ow.ly/PkSY50Q4o6F

Lovely lunch with Laura Dawson down under🇦🇺 Radiation Oncology #alumni

Honoured to be awarded ASCO Merit Award. Thanks to Dr. Andrew Loblaw for the opportunity to be involved in this work during my fellowship Sunnybrook Health Sciences Centre Radiation Oncology! #PATRIOT #GU24

1)🚨Just out The Lancet - CURB randomized phase 2 RCT of SBRT for oligoprogressive metastatic NSCLC and breast cancer. thelancet.com/journals/lance… Simon Powell Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Biostatistics Service Radiation Medicine Program Radiation Oncology The Princess Margaret Cancer Foundation Princess Margaret Cancer Centre Jonathan Yang Isabel Preeshagul

NEW: The International Society of Stereotactic Radiosurgery reviews the safety and efficacy of stereotactic body radiotherapy for primary renal cell carcinoma, forming the basis for practice guidelines. #rccsm #radonc thelancet.com/journals/lanon…

1/ For #KidneyCancerAwareness month The Lancet Oncology has a 50-day full link to TROG Cancer Research FASTRACK II! authors.elsevier.com/a/1ifvZ5EIIgPd…. Thank you Cancer Australia, ANZUP, Varian. A new #radiotherapy standard of care option for inoperable primary #kidneycancer #radonc

Glad to have Supiot Stéphane Down Under with us at #TROGASM24 and speaking at GU session. Looking forward to exploring collaboration opportunities between TROG Cancer Research and GETUG Also found out that we are all Radiation Oncology #alumni Prof Jarad Martin

Massive team effort to start The Alfred Prostate Stereotactic Ablative Body Radiotherapy (SABR) program - first public centre in Victoria to offer prostate SABR as standard of care treatment options on CT-Linac, cutting down treatment from 20 to 5 visits for prostate cancer!

Final anlyses of the Sunnybrook Health Sciences Centre GLIO study that proved tumour migration during fractionated rads for high grade glioma and now reporting prognostic relevance. Congrats to our prior fellow Dr. Wee Ong from 🇦🇺 and supervisor Dr. Myrehaug. pubmed.ncbi.nlm.nih.gov/38561051/

Good catch-up and moderating ISRSy #ISRSUSA2024 GU prostate SABR session with Rohann Correa, co-fellows Sunnybrook Health Sciences Centre Radiation Oncology Dr. Andrew Loblaw

Good to see RADICALS-HD in print. THanks to numerous colleagues and collaborators over 20 years authors.elsevier.com/sd/article/S01…

Team Aussie 🇦🇺 at #ReCOG. Definitely lots of collective work/ opportunities (eg reirradiation registry) to improve ReRT Down Under! Nick Hardcastle @RANZCRCollege

Another major milestone for The Alfred Radiation Oncology - now offering prostate SABR at our satellite site at Latrobe Regional Health LRH | Hospital, making treatment more convenient for men with prostate cancer in regional Victoria! Monash Partners Comprehensive Cancer Consortium (photo with patient consent)

Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful. In Search of Joy and Meaning in Modern Medicine JCO Oncology Practice ascopubs.org/doi/pdf/10.120…

Online First: #Palliative #radiotherapy versus best supportive care in patients with painful #hepaticcancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study #radonc thelancet.com/journals/lanon…